Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects

被引：2
|
作者：
Vaidyanathan, S [1 ]
Jermany, J [1 ]
Yeh, CM [1 ]
Bizot, MN [1 ]
Camisasca, RP [1 ]
机构：
[1] Novartis, Exploratory Clin Dev, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2005年 / 18卷 / 05期
关键词：
Japanese subjects; pharmacokinetics; renin inhibitor;
D O I：
10.1016/j.amjhyper.2005.03.208
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [1] Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects
    Vaidyanathan, Sujata
    Jermany, Joanne
    Yeh, ChingMing
    Bizot, Marie-Noelle
    Camisasca, Riccardo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 690 - 698
  • [2] Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor
    Buczko, Wlodzimierz
    Hermanowicz, Justyna M.
    PHARMACOLOGICAL REPORTS, 2008, 60 (05) : 623 - 631
  • [3] Pharmacokinetics and pharmacodynamics of rasburicase in Japanese and Caucasian subjects
    Berkenstock, R
    Turpault, S
    Kanamaluru, V
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1026 - 1026
  • [4] Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects
    Dieterle, W
    Corynen, S
    Mann, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 433 - 436
  • [5] Structure-based design of aliskiren, a novel orally effective renin inhibitor
    Wood, JM
    Maibaum, J
    Rahuel, J
    Grütter, MG
    Cohen, NC
    Rasetti, V
    Rüger, H
    Göschke, R
    Stutz, S
    Fuhrer, W
    Schilling, W
    Rigollier, P
    Yamaguchi, Y
    Cumin, F
    Baum, HP
    Schnell, CR
    Herold, P
    Mah, R
    Jensen, C
    O'Brien, E
    Stanton, A
    Bedigian, MP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (04) : 698 - 705
  • [6] Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects
    Chan, Clark
    Yeo, Kwee P.
    Pan, Alan X.
    Lim, Maggie
    Knadler, Mary P.
    Small, David S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 310 - 314
  • [7] Aliskiren, an orally effective renin inhibitor, shows dose linear pharmacokinetics in healthy volunteers.
    Vaidyanathan, S
    Limoges, D
    Yeh, C
    Dieterich, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P64 - P64
  • [8] Pharmacokinetics, safety and tolerability of the novel oral direct renin inhibitor aliskiren in elderly subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1072 - 1072
  • [9] Pharmacokinetics and pharmacodynamics of opicapone in healthy Japanese and matched Caucasian subjects
    Rocha, J. -F.
    Falcao, A.
    Lopes, N.
    Santos, A. T.
    Nunes, T.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2014, 29 : S261 - S261
  • [10] Pharmacokinetics, safety, and tolerability of the novel oral direct renin inhibitor aliskiren in elderly healthy subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04): : 453 - 460
12345